Clinical Trial Update: HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing HAV versus DAV/IAV induction regimens in elderly patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• DAV/IAV induction regimen
• HAV regimen

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | Phase 2 | Status: RECRUITING